Literature DB >> 19184473

Risk of cancer among rheumatoid arthritis patients in California.

Arti Parikh-Patel1, Richard H White, Mark Allen, Rosemary Cress.   

Abstract

OBJECTIVE: The objective of this retrospective cohort study was to evaluate cancer risk among rheumatoid arthritis (RA) patients in California.
METHODS: The study cohort derived from statewide patient discharge records was followed via linkage with cancer registry data over the period 1991-2002. Age and sex adjusted standardized incidence ratios (SIRs) and 95% confidence intervals were calculated to compare observed to expected numbers of cancers based on age, race, and sex specific incidence rates in the California population.
RESULTS: Among the 84,475 RA patients, who were observed for 405,540 person-years, 5,533 incident cancers were diagnosed during the observation interval. The risk of developing lymphohematopoietic cancer was significantly higher in the cohort for both sexes. Males had significantly higher risks of lung, liver, and esophageal cancer, but a lower risk of prostate cancer. Females were at significantly decreased risk for several cancers including breast, ovary, uterus, cervix, and melanoma, with the risk reduction ranging from 15 to 57% lower than the general population. Hispanics had increased risks of leukemia, vagina/vulva, lung, and liver cancers.
CONCLUSION: Studies investigating the mechanisms that underlie the reported associations between RA and specific cancer types are needed.

Entities:  

Mesh:

Year:  2009        PMID: 19184473      PMCID: PMC4354853          DOI: 10.1007/s10552-009-9298-y

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  54 in total

1.  Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population.

Authors:  Salaheddin M Mahmud; Simon Tanguay; Louis R Bégin; Eduardo L Franco; Armen G Aprikian
Journal:  Eur J Cancer Prev       Date:  2006-04       Impact factor: 2.497

Review 2.  Epidemiology of rheumatoid arthritis: update.

Authors:  M C Hochberg; T D Spector
Journal:  Epidemiol Rev       Date:  1990       Impact factor: 6.222

3.  Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.

Authors:  Eva Baecklund; Anastasia Iliadou; Johan Askling; Anders Ekbom; Carin Backlin; Fredrik Granath; Anca Irinel Catrina; Richard Rosenquist; Nils Feltelius; Christer Sundström; Lars Klareskog
Journal:  Arthritis Rheum       Date:  2006-03

4.  Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases.

Authors:  D P Symmons; M Ahern; P A Bacon; C F Hawkins; P L Amlot; E L Jones; P Prior; D L Scott
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

5.  Risk of malignancy among patients with rheumatic conditions.

Authors:  E Thomas; D H Brewster; R J Black; G J Macfarlane
Journal:  Int J Cancer       Date:  2000-11-01       Impact factor: 7.396

6.  Rheumatoid arthritis and chronic lymphatic leukaemia.

Authors:  H G Taylor; N Nixon; T P Sheeran; P T Dawes
Journal:  Clin Exp Rheumatol       Date:  1989 Sep-Oct       Impact factor: 4.473

7.  Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.

Authors:  Rachelle Buchbinder; Melissa Barber; Louise Heuzenroeder; Anita E Wluka; Graham Giles; Stephen Hall; Andrew Harkness; Daniel Lewis; Geoff Littlejohn; Marian H Miller; Peter F J Ryan; Damien Jolley
Journal:  Arthritis Rheum       Date:  2008-06-15

Review 8.  Malignancy in autoimmune diseases.

Authors:  L J Kinlen
Journal:  J Autoimmun       Date:  1992-04       Impact factor: 7.094

Review 9.  Paraneoplastic rheumatic disorders: a review.

Authors:  R C Butler; J M Thompson; A C Keat
Journal:  J R Soc Med       Date:  1987-03       Impact factor: 18.000

10.  Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.

Authors:  Antonio González-Pérez; Luis A García Rodríguez; Ruy López-Ridaura
Journal:  BMC Cancer       Date:  2003-10-31       Impact factor: 4.430

View more
  39 in total

1.  Family history of cancer and non-malignant diseases and risk of childhood acute lymphoblastic leukemia: a Children's Oncology Group Study.

Authors:  Heather Zierhut; Martha S Linet; Leslie L Robison; Richard K Severson; Logan Spector
Journal:  Cancer Epidemiol       Date:  2011-10-21       Impact factor: 2.984

2.  No overall increased risk of cancer in patients with rheumatoid arthritis: a nationwide dynamic cohort study in Taiwan.

Authors:  Wen-Kuan Huang; Meng-Jiun Chiou; Chang-Fu Kuo; Yung-Chang Lin; Kuang-Hui Yu; Lai-Chu See
Journal:  Rheumatol Int       Date:  2014-03-27       Impact factor: 2.631

3.  Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.

Authors:  Shir Azrielant; Shmuel Tiosano; Abdulla Watad; Naim Mahroum; Aaron Whitby; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

4.  Melanoma and rheumatoid arthritis (brief report).

Authors:  Sarah Perkins; Martin Cohen; Elham Rahme; Sasha Bernatsky
Journal:  Clin Rheumatol       Date:  2012-01-13       Impact factor: 2.980

Review 5.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

6.  The Clinical Usefulness of (18)F-FDG PET/CT in Patients with Systemic Autoimmune Disease.

Authors:  Jong-Ryool Oh; Ho-Chun Song; Sae-Ryung Kang; Su-Woong Yoo; Jahae Kim; Ari Chong; Jung-Joon Min; Hee-Seung Bom; Shin-Seok Lee; Yong-Wook Park
Journal:  Nucl Med Mol Imaging       Date:  2011-08-05

7.  Chronic disease burden among cancer survivors in the California Behavioral Risk Factor Surveillance System, 2009-2010.

Authors:  Heather P Tarleton; Suzanne Ryan-Ibarra; Marta Induni
Journal:  J Cancer Surviv       Date:  2014-04-09       Impact factor: 4.442

8.  The risk of leukemia in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Xiao Luo; Yue He; Wangdong Xu; Mao Liu; Zixia Zhao; Lihui Peng; Chengsong He; Jie Chen
Journal:  Clin Rheumatol       Date:  2020-09-17       Impact factor: 2.980

9.  Functional genomics and rheumatoid arthritis: where have we been and where should we go?

Authors:  James N Jarvis; Mark Barton Frank
Journal:  Genome Med       Date:  2010-07-28       Impact factor: 11.117

Review 10.  A review of the application of inflammatory biomarkers in epidemiologic cancer research.

Authors:  Darren R Brenner; Dominique Scherer; Kenneth Muir; Joellen Schildkraut; Paolo Boffetta; Margaret R Spitz; Loic Le Marchand; Andrew T Chan; Ellen L Goode; Cornelia M Ulrich; Rayjean J Hung
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-24       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.